The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting – The Washington Post

6 days ago

1 Views

1 Min Read

The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting The Washington Post
Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest The Guardian
Weight-loss jabs ‘slash cancer risk and boost survival rates’ The Times
GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30% U.S. News & World Report
Weight-loss drugs linked to lower breast cancer rates. What to know USA Today